This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

European Neurological Device Markets

NEW YORK, March 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

European Neurological Device Markets

http://www.reportlinker.com/p01048521/European-Neurological-Device-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment

In 2011, the total European market for neurological devices was valued at €628.3 million. Market growth will be driven by the continued acceptance of endovascular techniques and neuromodulation devices, increases in the aging population and technological advancements.

Scope: This report pertains to a forecast period of 10 years (2008 – 2018) for: Germany, France, U.K, Italy, Spain, Benelux, Scandinavia, Portugal, Austria, and Switzerland.

 

Report Contents:

Competitor Analysis

Identified Strategic Opportunities

Market Overview by Segment & Country

Trend Analysis by Segment & Country

Market Drivers & Limiters

Mergers & Acquisitions

Customer Feedback and Market Monitoring

 

Main Segments Included:

 

Cerebrospinal fluid (CSF) shunts

Neuromodulation

Detachable coils

Liquid embolics

Neurovascular catheters

Neurovascular guidewires

Neurovascular stents

Transcranial magnetic stimulators

Stereotactic systems

Neurosurgical microscopes

 

Companies Included (Partial List):

 

Medtronic

Codman

Aesculap

Sophysa

Integra LifeSciences

Stryker (Boston Scientific)

Terumo (MicroVention)

Covidien (ev3, Inc.)

Penumbra Inc.

 

Reasons To Buy:

 

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "bottom up" approach, which includes primary and secondary research methods

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs